Atlas Trials

Moderate to Severe Psoriasis

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Moderate to Severe Psoriasis

RecordFirmDate
Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing (NCT05344248)Shanghai Junshi Bioscience Co., Ltd.2021-01-20
A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis (NCT03051217)UCB Biopharma S.P.R.L.2017-02-21
Biologics Anchoring Study (NCT03026153)Wake Forest University Health Sciences2016-10-01
Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy (NCT01237262)University of Padova2010-11-01
Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy (NCT01156532)AbbVie (prior sponsor, Abbott)2010-11-01
Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis (NCT00936065)Pfizer2009-07-01
Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis (NCT00678470)University of California, San Francisco2007-09-01
Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis (NCT00442650)Merck KGaA, Darmstadt, Germany2004-01-01
CLEAR Study: Clinical Experience Acquired With Raptiva Study (NCT00256139)Merck KGaA, Darmstadt, Germany2003-03-01

Track Moderate to Severe Psoriasis automatically

Every clearance here is in the API, with alerts when new ones post.